Trials / Unknown
UnknownNCT04351321
The Safety of Totally Laparoscopic Versus Laparoscopy-Assisted Total Gastrectomy.
A Multicenter, Randomized, Controlled Clinical Trial of the Safety of Totally Laparoscopic Versus Laparoscopy-Assisted Total Gastrectomy for Gastric Cancer.
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 560 (estimated)
- Sponsor
- The First Affiliated Hospital with Nanjing Medical University · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
To compare the short-term surgical safety and postoperative quality of life of totally laparoscopic versus laparoscopy-assisted total gastrectomy and to evaluate the superiority of totally laparoscopic total gastrectomy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Totally Laparoscopic Total Gastrectomy | Totally laparoscopic total gastrectomy will be performed in patients with gastric or esophagogastric junction adenocarcinoma of preoperative clinical stage I (T1N0M0, T1N1M0, T2N0M0) with D1+/D2 lymph node dissection. |
| PROCEDURE | Laparoscopy-Assisted Total Gastrectomy | Laparoscopy-Assisted Total Gastrectomy will be performed in patients with gastric or esophagogastric junction adenocarcinoma of preoperative clinical stage I (T1N0M0, T1N1M0, T2N0M0) with D1+/D2 lymph node dissection. |
Timeline
- Start date
- 2020-07-01
- Primary completion
- 2022-08-01
- Completion
- 2023-08-01
- First posted
- 2020-04-17
- Last updated
- 2020-04-17
Source: ClinicalTrials.gov record NCT04351321. Inclusion in this directory is not an endorsement.